Copyright Reports & Markets. All rights reserved.

Global Hemostatic Gel Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Hemostatic Gel
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hemostatic Gel Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Fibrin
    • 1.3.3 Gelatin
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hemostatic Gel Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Minimally Invasive Surgery
    • 1.4.3 General Surgery
    • 1.4.4 Others
  • 1.5 Global Hemostatic Gel Market Size & Forecast
    • 1.5.1 Global Hemostatic Gel Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Hemostatic Gel Sales Quantity (2018-2029)
    • 1.5.3 Global Hemostatic Gel Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Baxter
    • 2.1.1 Baxter Details
    • 2.1.2 Baxter Major Business
    • 2.1.3 Baxter Hemostatic Gel Product and Services
    • 2.1.4 Baxter Hemostatic Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Baxter Recent Developments/Updates
  • 2.2 J&J
    • 2.2.1 J&J Details
    • 2.2.2 J&J Major Business
    • 2.2.3 J&J Hemostatic Gel Product and Services
    • 2.2.4 J&J Hemostatic Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 J&J Recent Developments/Updates
  • 2.3 CryoLife
    • 2.3.1 CryoLife Details
    • 2.3.2 CryoLife Major Business
    • 2.3.3 CryoLife Hemostatic Gel Product and Services
    • 2.3.4 CryoLife Hemostatic Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 CryoLife Recent Developments/Updates
  • 2.4 Integra Life Sciences
    • 2.4.1 Integra Life Sciences Details
    • 2.4.2 Integra Life Sciences Major Business
    • 2.4.3 Integra Life Sciences Hemostatic Gel Product and Services
    • 2.4.4 Integra Life Sciences Hemostatic Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Integra Life Sciences Recent Developments/Updates
  • 2.5 Advance Medical Solution
    • 2.5.1 Advance Medical Solution Details
    • 2.5.2 Advance Medical Solution Major Business
    • 2.5.3 Advance Medical Solution Hemostatic Gel Product and Services
    • 2.5.4 Advance Medical Solution Hemostatic Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Advance Medical Solution Recent Developments/Updates
  • 2.6 BD
    • 2.6.1 BD Details
    • 2.6.2 BD Major Business
    • 2.6.3 BD Hemostatic Gel Product and Services
    • 2.6.4 BD Hemostatic Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 BD Recent Developments/Updates
  • 2.7 CSL Behring
    • 2.7.1 CSL Behring Details
    • 2.7.2 CSL Behring Major Business
    • 2.7.3 CSL Behring Hemostatic Gel Product and Services
    • 2.7.4 CSL Behring Hemostatic Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 CSL Behring Recent Developments/Updates
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer Hemostatic Gel Product and Services
    • 2.8.4 Pfizer Hemostatic Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Pfizer Recent Developments/Updates
  • 2.9 B Braun
    • 2.9.1 B Braun Details
    • 2.9.2 B Braun Major Business
    • 2.9.3 B Braun Hemostatic Gel Product and Services
    • 2.9.4 B Braun Hemostatic Gel Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 B Braun Recent Developments/Updates

3 Competitive Environment: Hemostatic Gel by Manufacturer

  • 3.1 Global Hemostatic Gel Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Hemostatic Gel Revenue by Manufacturer (2018-2023)
  • 3.3 Global Hemostatic Gel Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Hemostatic Gel by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Hemostatic Gel Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Hemostatic Gel Manufacturer Market Share in 2022
  • 3.5 Hemostatic Gel Market: Overall Company Footprint Analysis
    • 3.5.1 Hemostatic Gel Market: Region Footprint
    • 3.5.2 Hemostatic Gel Market: Company Product Type Footprint
    • 3.5.3 Hemostatic Gel Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hemostatic Gel Market Size by Region
    • 4.1.1 Global Hemostatic Gel Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Hemostatic Gel Consumption Value by Region (2018-2029)
    • 4.1.3 Global Hemostatic Gel Average Price by Region (2018-2029)
  • 4.2 North America Hemostatic Gel Consumption Value (2018-2029)
  • 4.3 Europe Hemostatic Gel Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Hemostatic Gel Consumption Value (2018-2029)
  • 4.5 South America Hemostatic Gel Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Hemostatic Gel Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Hemostatic Gel Sales Quantity by Type (2018-2029)
  • 5.2 Global Hemostatic Gel Consumption Value by Type (2018-2029)
  • 5.3 Global Hemostatic Gel Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Hemostatic Gel Sales Quantity by Application (2018-2029)
  • 6.2 Global Hemostatic Gel Consumption Value by Application (2018-2029)
  • 6.3 Global Hemostatic Gel Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Hemostatic Gel Sales Quantity by Type (2018-2029)
  • 7.2 North America Hemostatic Gel Sales Quantity by Application (2018-2029)
  • 7.3 North America Hemostatic Gel Market Size by Country
    • 7.3.1 North America Hemostatic Gel Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Hemostatic Gel Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Hemostatic Gel Sales Quantity by Type (2018-2029)
  • 8.2 Europe Hemostatic Gel Sales Quantity by Application (2018-2029)
  • 8.3 Europe Hemostatic Gel Market Size by Country
    • 8.3.1 Europe Hemostatic Gel Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Hemostatic Gel Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hemostatic Gel Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Hemostatic Gel Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Hemostatic Gel Market Size by Region
    • 9.3.1 Asia-Pacific Hemostatic Gel Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Hemostatic Gel Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Hemostatic Gel Sales Quantity by Type (2018-2029)
  • 10.2 South America Hemostatic Gel Sales Quantity by Application (2018-2029)
  • 10.3 South America Hemostatic Gel Market Size by Country
    • 10.3.1 South America Hemostatic Gel Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Hemostatic Gel Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hemostatic Gel Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Hemostatic Gel Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Hemostatic Gel Market Size by Country
    • 11.3.1 Middle East & Africa Hemostatic Gel Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Hemostatic Gel Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Hemostatic Gel Market Drivers
  • 12.2 Hemostatic Gel Market Restraints
  • 12.3 Hemostatic Gel Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hemostatic Gel and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hemostatic Gel
  • 13.3 Hemostatic Gel Production Process
  • 13.4 Hemostatic Gel Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hemostatic Gel Typical Distributors
  • 14.3 Hemostatic Gel Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.
    According to our (Global Info Research) latest study, the global Hemostatic Gel market size was valued at USD 974.7 million in 2022 and is forecast to a readjusted size of USD 1369.4 million by 2029 with a CAGR of 5.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.
    North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.
    In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.
    This report is a detailed and comprehensive analysis for global Hemostatic Gel market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Hemostatic Gel market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Hemostatic Gel market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Hemostatic Gel market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Hemostatic Gel market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hemostatic Gel
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hemostatic Gel market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, J&J, CryoLife, Integra Life Sciences and Advance Medical Solution, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Hemostatic Gel market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Fibrin
    Gelatin
    Other
    Market segment by Application
    Minimally Invasive Surgery
    General Surgery
    Others
    Major players covered
    Baxter
    J&J
    CryoLife
    Integra Life Sciences
    Advance Medical Solution
    BD
    CSL Behring
    Pfizer
    B Braun
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hemostatic Gel product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hemostatic Gel, with price, sales, revenue and global market share of Hemostatic Gel from 2018 to 2023.
    Chapter 3, the Hemostatic Gel competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hemostatic Gel breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hemostatic Gel market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hemostatic Gel.
    Chapter 14 and 15, to describe Hemostatic Gel sales channel, distributors, customers, research findings and conclusion.

    Buy now